Home > Insider Trading > Filing (0001209191-24-001655)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840233	Xilio Therapeutics Inc.	XLO	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1708269	Atlas Venture Fund Xi, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1759241	Atlas Venture Opportunity Fund I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780065	Atlas Venture Associates Opportunity I, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780066	Atlas Venture Associates Opportunity I, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780067	Atlas Venture Associates Xi, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No
1780068	Atlas Venture Associates Xi, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-01-11	1,566	$0.87	2,021,836	No	4	S	Direct
Common Stock	Disposition	2024-01-11	569	$0.87	735,373	No	4	S	Indirect	See footnote
Common Stock	Disposition	2024-01-12	1,540	$0.83	2,020,296	No	4	S	Direct
Common Stock	Disposition	2024-01-12	560	$0.83	734,813	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Direct
No	4	S	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.9499 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any.
The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.